Fluorophores including fluorescent dyes/proteins and quantum dots (QDs) are used for fluorescence-based imaging and detection. These are based on ‘downconversion fluorescence’ and have several drawbacks: photobleaching,
autofluorescence, short tissue penetration depth and tissue photo-damage. Upconversion fluorescent nanoparticles
(UCNs) emit detectable photons of higher energy in the short wavelength range upon irradiation with near-infrared
(NIR) light based on a process termed ‘upconversion’. UCNs show absolute photostability, negligible autofluorescence, high penetration depth and minimum photodamage to biological tissues. Lanthanide doped nanocrystals with nearinfrared NIR-to-NIR and/or NIR-to-VIS and/or NIR-to-UV upconversion fluorescence emission have been synthesized. The nanocrystals with small size and tunable multi-color emission have been developed. The emission can be tuned by doping different upconverting lanthanide ions into the nanocrystals. The nanocrystals with core-shell structure have also been prepared to tune the emission color. The surfaces of these nanocrystals have been modified to render them water dispersible and biocompatible. They can be used for ultrasensitive interference-free biodetection because most biomolecules do not have upconversion properties. UCNs are also useful for light based therapy with enhanced efficiency, for example, photoactivation.
Nanoparticle-based delivery of drugs has gained a lot of prominence recently but the main problem hampering efficient delivery of payload is the clearing or degradation of nanoparticles by endosomes. Various strategies have been used to overcome this issue and one such effective solution is Photochemical Internalization (PCI). This technique involves the activation of certain photosensitizing compounds by light, which accumulate specifically in the membranes of endocytic vesicles. The activated photosensitizers induce the formation of reactive oxygen species which in turn induces localized disruption of endosomal membranes. But the drawback of this technique is that it needs blue light for activation and hence confined to be used only in in-vitro systems due to the poor tissue penetration of blue light. Here, we report the use of Upconversion nanoparticles (UCNs) as a transducer for activation of the photosensitizer, TPPS 2a. NIR light has good tissue penetrating ability and thus enables PCI in greater depths. Highly monodisperse, uniformly-sized, sub-100 nm, biocompatible upconversion nanoparticles were synthesized with a mesoporous silica coating. These UCNs activated TPPS 2a efficiently in solution and in cells. Paclitaxel, an anti-cancer drug was used as a model drug and was loaded into the mesoporous silica coating. B16F0 cells transfected with drug-loaded UCNs and irradiated with NIR showed significantly higher nanoparticle uptake and in turn higher cell death caused by the delivered drug. This technique can be used to enhance the delivery of any therapeutic molecule and thus increase the therapeutic efficiency considerably.
Lanthanide doped nanocrystals with upconversion fluorescence emission have been synthesized. The surface of these
nanocrystals are modified to render them water dispersible and biocompatible. Use of these nanocrystals for bioimaging
introduces many advantages, for example, minimum photo-damage to biological samples, weak auto-fluorescence, high
detection sensitivity, high light penetration depth, etc. Here, we use upconversion nanocrystals to label cancer cells and
demonstrate confocal imaging of the labeled cells implanted in mouse muscle.
Using a light-based approach known as photodynamic therapy (PDT), we explore a new method in tackling viral
pathogens via the excitation of light-sensitive materials called photosensitizers to produce reactive oxygen species which
mediates the inactivation of viruses. Photosensitizers are loaded into mesoporous silica coated upconversion
nanoparticles to photodynamically inactivate viruses in suspension.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.